Generation bio reports third quarter 2020 business updates and financial results

On track to advance lead programs into pre-clinical development in 2021 supported by key leadership team appointments on track to advance lead programs into pre-clinical development in 2021 supported by key leadership team appointments

GBIO Ratings Summary

GBIO Quant Ranking